A Pragmatic Trial of a Shared Decision-Making Intervention to Improve Medication Adherence and Outcomes in Systemic Lupus Erythematosus: The HCQ-SAFE Study - Scorecard - MDSpire
Advertisement
A Practical Study on a Collaborative Decision-Making Approach to Enhance Medication Compliance and Health Outcomes in Systemic Lupus Erythematosus: The HCQ-SAFE Investigation
Clinical Scorecard: A Practical Study on a Collaborative Decision-Making Approach to Enhance Medication Compliance and Health Outcomes in Systemic Lupus Erythematosus: The HCQ-SAFE Investigation
At a Glance
Category
Detail
Condition
Systemic Lupus Erythematosus (SLE)
Key Mechanisms
Hydroxychloroquine (HCQ) prolongs disease-free and damage-free survival.
Target Population
Patients aged 18 years or older with a validated SLE diagnosis.
Care Setting
Rheumatology and lupus clinics
Key Highlights
83% of patients discontinue HCQ, leading to higher hospitalizations and mortality.
Shared decision-making (SDM) tools can reduce decisional conflicts and improve adherence.
Culturally appropriate e-versions of HCQ-SAFE were developed for English and Spanish speakers.
The study included patients with varying durations of HCQ use and aimed for diverse representation.
Guideline-Based Recommendations
Diagnosis
Validated SLE diagnosis according to the 2019 EULAR/American College of Rheumatology classification criteria.
Management
Use of HCQ as the cornerstone therapy for SLE.
Monitoring & Follow-up
Evaluate adherence and decisional conflicts using HCQ-SAFE tool.
Risks
Potential for macular toxicity associated with HCQ use.
Patient & Prescribing Data
Patients with SLE, including those reporting Spanish as their primary language.
Patients often face challenges in weighing benefits and harms of HCQ.
Clinical Best Practices
Implement shared decision-making tools in clinical practice.
Ensure culturally appropriate communication and materials for diverse patient populations.
by Caroline Packee, Jay J. Patel, Jessica Kent, Betty Chewning, Sancia Ferguson, Patricia Tellez-Giron, David Gazeley, Christie M. Bartels, Shivani Garg
A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.
